FR10C0036I2 - - Google Patents

Info

Publication number
FR10C0036I2
FR10C0036I2 FR10C0036C FR10C0036C FR10C0036I2 FR 10C0036 I2 FR10C0036 I2 FR 10C0036I2 FR 10C0036 C FR10C0036 C FR 10C0036C FR 10C0036 C FR10C0036 C FR 10C0036C FR 10C0036 I2 FR10C0036 I2 FR 10C0036I2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR10C0036C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18447824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR10C0036(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of FR10C0036I1 publication Critical patent/FR10C0036I1/fr
Application granted granted Critical
Publication of FR10C0036I2 publication Critical patent/FR10C0036I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
FR10C0036C 1992-12-02 2010-07-19 Active FR10C0036I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35619792 1992-12-02

Publications (2)

Publication Number Publication Date
FR10C0036I1 FR10C0036I1 (en) 2010-08-27
FR10C0036I2 true FR10C0036I2 (en) 2011-04-29

Family

ID=18447824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR10C0036C Active FR10C0036I2 (en) 1992-12-02 2010-07-19

Country Status (7)

Country Link
US (1) US5387603A (en)
EP (1) EP0600675B1 (en)
JP (1) JP2944402B2 (en)
KR (1) KR100274329B1 (en)
CA (1) CA2110454C (en)
DE (2) DE69319551T2 (en)
FR (1) FR10C0036I2 (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015202A1 (en) * 1997-09-22 1999-04-01 Kissei Pharmaceutical Co., Ltd. Remedies for dysuria resulting from prostatic hypertrophy
PL342477A1 (en) * 1998-02-27 2001-06-04 Kissei Pharmaceutical Derivatives of indole and pharmacological compositions containing them
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
JP4634560B2 (en) * 2000-01-14 2011-02-16 キッセイ薬品工業株式会社 Process for producing optically active indoline derivative and production intermediate thereof
AU2001256714A1 (en) * 2000-05-15 2001-11-26 Kissei Pharmaceutical Co. Ltd. Water-based liquid preparation
AU2001256733A1 (en) 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
JP4921646B2 (en) * 2001-03-08 2012-04-25 キッセイ薬品工業株式会社 1- (3-Benzyloxypropyl) -5- (2-substituted propyl) indoline derivatives and methods of use thereof
DK1293198T3 (en) * 2001-09-14 2005-06-06 Sanol Arznei Schwarz Gmbh Transdermal administration device for the treatment of urinary tract disorders
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
MXPA05006513A (en) 2002-12-16 2005-09-08 Kissei Pharmaceutical Solid drug for oral use.
EP1724257B1 (en) 2004-03-05 2013-11-13 Kissei Pharmaceutical Co., Ltd. Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
JP4847333B2 (en) * 2004-09-06 2011-12-28 キッセイ薬品工業株式会社 Drugs for preventing or treating dysuria
BRPI0517515B8 (en) * 2004-10-27 2021-05-25 Kissei Pharmaceutical indoline compound, as well as methods for producing indoline compounds
EA016008B1 (en) * 2005-11-24 2012-01-30 Киссеи Фармасьютикал Ко., Лтд. Pharmaceutical for use in the treatment of ureterolithiasis
CN101190890B (en) 2006-11-30 2011-04-27 江苏豪森药业股份有限公司 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxyl)phenoxyl]ethyl]amino]propyl]-2-methoxylbenzsulfamide
EP2125717B1 (en) * 2007-02-26 2013-07-03 Concert Pharmaceuticals Inc. Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists
US20100076010A1 (en) * 2007-02-26 2010-03-25 Concert Pharmaceuticals, Inc. Alpha 1a-adrenoceptor antagonists
MX2009009230A (en) * 2007-02-28 2009-11-26 Kissei Pharmaceutical Use of silodosin in a once daily administration for treating benign prostatic hyperplasia.
CN101993405B (en) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 Indoline derivative as well as preparation method and application thereof
CN101993407B (en) * 2009-08-27 2014-01-29 浙江华海药业股份有限公司 Indoline compound for preparing silodosin and preparation method thereof
US8471039B2 (en) * 2009-09-12 2013-06-25 Sandoz Ag Process for the preparation of indoline derivatives and their intermediates thereof
CN101768056B (en) * 2010-01-19 2013-10-16 扬子江药业集团有限公司 Preparation method of substituted phenyl methyl ether
WO2011101864A1 (en) 2010-02-17 2011-08-25 Panacea Biotec Ltd Novel process for the synthesis of phenoxyethyl derivatives
WO2011124704A1 (en) 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
EP2585050B1 (en) 2010-06-28 2014-05-14 Ratiopharm GmbH Silodosin-cyclodextrine inclusion complex
CN102311319A (en) * 2010-07-05 2012-01-11 浙江华海药业股份有限公司 Method for preparing 2-(2,2,2-trifluoroethyl) anisole
EP2595607A2 (en) 2010-07-23 2013-05-29 Ratiopharm GmbH Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer
WO2012014186A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates
WO2012062229A1 (en) 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide
WO2012077138A1 (en) 2010-12-09 2012-06-14 Panacea Biotec Limited Methods of crystallizing (r) -1- (3 -hydroxypropyl) -5- [2- [2- [2- ( 2, 2, 2 - trifluoroethoxy) phenoxy] ethylamino] propyl] indoline-7 -carboxamide
CN102050709B (en) * 2010-12-22 2014-09-10 合肥信风科技开发有限公司 Method for preparing 2-[2-(2,2,2-trifluoro-ethyoxyl) phenoxyl] alcohol
US20120184591A1 (en) 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102643221B (en) 2011-02-22 2015-02-11 浙江九洲药业股份有限公司 Silodosin intermediate and preparation method thereof
WO2012131710A2 (en) 2011-03-30 2012-10-04 Panacea Biotec Ltd Novel process for the synthesis of indoline derivatives
WO2012147107A2 (en) * 2011-04-29 2012-11-01 Msn Laboratories Limited Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition
CN102285872A (en) * 2011-06-17 2011-12-21 连云港万科生物科技有限公司 Method for preparing 2-[2,2,2(trifluoroethoxy)-phenoxy ethanol
CN102382029B (en) * 2011-07-26 2016-06-29 浙江华海药业股份有限公司 A kind of salt formation of silodosin intermediate preparation method
CN102283816B (en) * 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 Silodosin sustained-release tablet and preparation method thereof
WO2013061338A1 (en) 2011-08-24 2013-05-02 Cadila Healthcare Limited Pharmaceutical compositions of silodosin
WO2013072935A2 (en) 2011-10-10 2013-05-23 Cadila Healthcare Limited Process for the preparation of silodosin
US20150038727A1 (en) 2011-10-21 2015-02-05 Sandoz Ag Method for preparing silodosin
CN102675182B (en) * 2012-05-24 2014-03-26 临海天宇药业有限公司 Preparing method of 1-(3-benzoyloxy propyl)-5-(2-oxopropyl)-7-indolinecarbonitrile
CN102690223A (en) * 2012-05-24 2012-09-26 临海天宇药业有限公司 Preparation method for 1-acetyl-7-cyanopyridine-5-(2-amino propyl) indoline
EP2909327A1 (en) * 2012-10-18 2015-08-26 Sandoz AG A process for preparing indoline derivatives
CN103848772A (en) * 2012-11-30 2014-06-11 苏州四同医药科技有限公司 Preparation method of important intermediate of Silodosin
EP2979697A4 (en) 2013-03-26 2016-11-30 Kissei Pharmaceutical Oral administration preparation with masked bitterness of silodosin
CN105102429A (en) * 2013-04-09 2015-11-25 曼康德研究中心 N-haloalkylindoline intermediates, process and use in preparation of silodosin and derivatives thereof
CN104140389A (en) * 2013-05-06 2014-11-12 昆明积大制药股份有限公司 Preparing method of silodosin and intermediate thereof
CN104326963A (en) * 2013-07-22 2015-02-04 中国科学院上海药物研究所 Indoline-like compound and preparation method, pharmaceutical composition and application thereof
CN104744336B (en) * 2013-12-26 2017-07-14 安徽省庆云医药股份有限公司 A kind of Silodosin intermediate and preparation method thereof, and the method for preparing with the intermediate silodosin
CN104974072B (en) * 2014-04-10 2017-11-03 江苏和成新材料有限公司 A kind of method for preparing Silodosin intermediate
KR101725393B1 (en) * 2014-07-24 2017-04-27 주식회사 경보제약 Manufacturing method for Silodosin and new intermediate thereof
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
KR101673160B1 (en) 2014-10-24 2016-11-07 보령제약 주식회사 Preparing Method of Silodosin Crystal Form
JP2016088847A (en) * 2014-10-30 2016-05-23 株式会社トクヤマ Method for producing (-)-1-(3-hydroxypropyl)-5-[[(2r)-2-({2-[2-(2,2,2-trifluoro ethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1h-indole-7-carboxamide])
KR20180055851A (en) 2015-09-23 2018-05-25 바이오콘 리미티드 The crystalline forms of the posaconazole intermediate and the method for preparing the amorphous posaconazole
ES2607639B1 (en) 2015-09-30 2018-02-28 Urquima, S.A Maleic acid salt of a silodosin intermediate
WO2018100565A1 (en) * 2016-11-30 2018-06-07 Granules India Limited Process for the preparation of indoline compound
CN107056675B (en) 2017-05-10 2019-09-03 浙江天宇药业股份有限公司 A kind of synthetic method of silodosin and its intermediate
KR102163068B1 (en) * 2018-07-04 2020-10-07 주식회사 가피바이오 The manufacturing method of intermediate for synthesis of silodosin and the manufacturing method of silodosin
CN109516933B (en) * 2018-10-29 2021-03-02 安徽省庆云医药股份有限公司 Preparation method of silodosin intermediate
EP3892615A1 (en) 2020-04-09 2021-10-13 Minakem Process for the preparation of silodosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA77657A (en) * 1902-09-11 1902-10-07 Adam A. Welsh Cable grip
US4638070A (en) * 1978-12-21 1987-01-20 Continental Pharma Heterocyclic amino-alcohol derivatives
FR2512817A1 (en) * 1981-09-17 1983-03-18 Roussel Uclaf NOVEL AMINOMETHYL 1H-INDOLE-4-METHANOL DERIVATIVES AND THEIR SALTS, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS COMPRISING THEM AND THEIR PREPARATION INTERMEDIATES
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
US4971990A (en) * 1988-02-19 1990-11-20 Hokuriku Pharmaceutical Co., Ltd. Phenoxyethylamine derivatives, for preparing the same and composition for exhibiting excellent α1 -blocking activity containing the same

Also Published As

Publication number Publication date
JP2944402B2 (en) 1999-09-06
CA2110454A1 (en) 1994-06-03
US5387603A (en) 1995-02-07
KR940014328A (en) 1994-07-18
JPH06220015A (en) 1994-08-09
EP0600675A1 (en) 1994-06-08
CA2110454C (en) 2005-10-25
DE122010000031I1 (en) 2010-10-21
FR10C0036I1 (en) 2010-08-27
DE69319551D1 (en) 1998-08-13
DE69319551T2 (en) 1998-10-29
EP0600675B1 (en) 1998-07-08
KR100274329B1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
FR10C0036I2 (en)
DE9205294U1 (en)
DE9200232U1 (en)
DE9200239U1 (en)
DE9200425U1 (en)
DE9200361U1 (en)
DE9200028U1 (en)
DE9200253U1 (en)
DE9200264U1 (en)
DE9200341U1 (en)
DE9200432U1 (en)
DE9200060U1 (en)
DE9200205U1 (en)
DE9200161U1 (en)
DE9200438U1 (en)
DE9200360U1 (en)
DE9207620U1 (en)
DE9200355U1 (en)
DE9200246U1 (en)
DE9200108U1 (en)
DE9200362U1 (en)
DE9200014U1 (en)
DE9205275U1 (en)
DE9200243U1 (en)
DE9217815U1 (en)